ICON Public Limited Company

NASDAQ (USD): ICON Public Limited Company (ICLR)

Last Price

195.60

Today's Change

+8.38 (4.47%)

Day's Change

185.37 - 195.67

Trading Volume

1,491,057

Overview

Market Cap

16 Billion

Shares Outstanding

82 Million

Avg Volume

1,073,193

Avg Price (50 Days)

264.80

Avg Price (200 Days)

303.48

PE Ratio

21.76

EPS

8.99

Earnings Announcement

19-Feb-2025

Previous Close

187.22

Open

186.79

Day's Range

185.375 - 195.675

Year Range

183.38 - 347.72

Trading Volume

1,491,057

Price Change Highlight

1 Day Change

4.48%

5 Day Change

-4.12%

1 Month Change

-34.30%

3 Month Change

-39.80%

6 Month Change

-37.85%

Ytd Change

-30.34%

1 Year Change

-27.56%

3 Year Change

-31.66%

5 Year Change

25.84%

10 Year Change

264.11%

Max Change

2975.77%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment